Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Esophageal Neoplasms 1Atrial Fibrillation 1

Interventions

Specimen Handling 118Magnetic Resonance Spectroscopy 115Cyclophosphamide 98pembrolizumab 82Radiotherapy 78Nivolumab 67Cisplatin 64fludarabine 59Biopsy 55Carboplatin 53Standard of Care 45Radiosurgery 43Dexamethasone 40Gemcitabine 39Radiation 37Paclitaxel 36venetoclax 35Rituximab 35Cytarabine 35Bevacizumab 35Surveys and Questionnaires 34Doxorubicin 33fludarabine phosphate 31Temozolomide 31Radiotherapy, Intensity-Modulated 30Capecitabine 30Practice Guidelines as Topic 29Blood Specimen Collection 29Interviews as Topic 28Fluorouracil 27

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Amiodarone × 30 days × Clear all
NCT06067438 2026-05-22

Amiodarone for the Prevention of Atrial Fibrillation After Minimally Invasive Esophagectomy in Patients With Esophageal Cancer

OHSU Knight Cancer Institute

Phase 2 Recruiting
90 enrolled
Gastrointestinal

Atrial Fibrillation, Esophageal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡